SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:kth-339001"
 

Sökning: id:"swepub:oai:DiVA.org:kth-339001" > Magnetically-assist...

Magnetically-assisted viral transduction (magnetofection) medical applications : An update

Azadpour, Behnam (författare)
Department of Materials Science and Engineering, Sharif University of Technology, Tehran, Iran
Aharipour, Nazli (författare)
Department of Materials Science and Engineering, Sharif University of Technology, Tehran, Iran
Paryab, Amirhosein (författare)
Department of Materials Science and Engineering, Sharif University of Technology, Tehran, Iran
visa fler...
Omid, Hamed (författare)
Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran, Iran
Abdollahi, Sorosh (författare)
Department of Biomedical Engineering, University of Calgary, Alberta, Canada
Madaah Hosseini, Hamidreza (författare)
Department of Materials Science and Engineering, Sharif University of Technology, Tehran, Iran
Malek Khachatourian, Adrine (författare)
Department of Materials Science and Engineering, Sharif University of Technology, Tehran, Iran
Toprak, Muhammet, 1973- (författare)
KTH,Biomedicinsk fysik och röntgenfysik
Seifalian, Alexander M. (författare)
Nanotechnology & Regenerative Medicine Commercialisation Centre (NanoRegMed Ltd, Nanoloom Ltd, & Liberum Health Ltd), London BioScience Innovation Centre, London, UK
visa färre...
 (creator_code:org_t)
Elsevier BV, 2023
2023
Engelska.
Ingår i: Biomaterials Advances. - : Elsevier BV. - 2772-9516 .- 2772-9508. ; 154
  • Forskningsöversikt (refereegranskat)
Abstract Ämnesord
Stäng  
  • Gene therapy involves replacing a faulty gene or adding a new gene inside the body's cells to cure disease or improve the body's ability to fight disease. Its popularity is evident from emerging concepts such as CRISPR-based genome editing and epigenetic studies and has been moved to a clinical setting. The strategy for therapeutic gene design includes; suppressing the expression of pathogenic genes, enhancing necessary protein production, and stimulating the immune system, which can be incorporated into both viral and non-viral gene vectors. Although non-viral gene delivery provides a safer platform, it suffers from an inefficient rate of gene transfection, which means a few genes could be successfully transfected and expressed within the cells. Incorporating nucleic acids into the viruses and using these viral vectors to infect cells increases gene transfection efficiency. Consequently, more cells will respond, more genes will be expressed, and sustained and successful gene therapy can be achieved. Combining nanoparticles (NPs) and nucleic acids protects genetic materials from enzymatic degradation. Furthermore, the vectors can be transferred faster, facilitating cell attachment and cellular uptake. Magnetically assisted viral transduction (magnetofection) enhances gene therapy efficiency by mixing magnetic nanoparticles (MNPs) with gene vectors and exerting a magnetic field to guide a significant number of vectors directly onto the cells. This research critically reviews the MNPs and the physiochemical properties needed to assemble an appropriate magnetic viral vector, discussing cellular hurdles and attitudes toward overcoming these barriers to reach clinical gene therapy perspectives. We focus on the studies conducted on the various applications of magnetic viral vectors in cancer therapies, regenerative medicine, tissue engineering, cell sorting, and virus isolation.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Mikrobiologi inom det medicinska området (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Microbiology in the medical area (hsv//eng)

Nyckelord

Cancer gene therapy
Magnetic nanoparticles
Magnetically-assisted viral gene delivery
Magnetofection
Transfection

Publikations- och innehållstyp

ref (ämneskategori)
for (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy